Literature DB >> 3731763

Relapse of neuroleptic malignant syndrome with early discontinuation of amantadine therapy.

P Hamburg, J B Weilburg, N H Cassem, L Cohen, S Brown.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3731763     DOI： 10.1016/0010-440x(86)90002-7

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN： 0010-440X            Impact factor:   3.735


× No keyword cloud information.
  5 in total

1.  Case files of the program in medical toxicology at brown university: amantadine withdrawal and the neuroleptic malignant syndrome.

Authors:  Eric Brantley; Jamieson Cohn; Kavita Babu
Journal:  J Med Toxicol       Date:  2009-06

2.  Amantadine in neuroleptic malignant syndrome.

Authors:  A Jee
Journal:  Postgrad Med J       Date:  1987-06       Impact factor: 2.401

3.  Neuroleptic malignant syndrome: a review.

Authors:  R A O'Brien; G B Young
Journal:  Can Fam Physician       Date:  1989-05       Impact factor: 3.275

4.  Amantadine and the glutamate hypothesis of schizophrenia. Experiences in the treatment of neuroleptic malignant syndrome.

Authors:  J Kornhuber; M Weller
Journal:  J Neural Transm Gen Sect       Date:  1993

5.  Case reports of neuroleptic malignant syndrome in context of quetiapine use.

Authors:  Mark B Detweiler; Kelly Sullivan; Taral R Sharma; Kye Y Kim; Jonna G Detweiler
Journal:  Psychiatr Q       Date:  2013-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.